We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App




RT-PCR Test Detects Monkeypox Virus Delivers Results in 90 Minutes

By LabMedica International staff writers
Posted on 29 Jun 2022

Monkeypox is an acute zoonotic infection disease caused by the monkeypox virus (MPXV). More...

The disease is mainly transmitted by animals, but it can also be transmitted from person to person through physical contact, body fluids, or even contaminated objects, showing symptoms such as fever, severe headache, and muscle pain. As with many infectious diseases, accurate diagnosis is crucial as treatments are more effective in the early stages of infection. PCR test is known as the gold standard to accurately detect MPXV, so it can be used effectively to prevent the rapid spread of the virus. Timely PCR testing vital, especially for individuals with a suspected case, as the incubation period for the monkeypox infection ranges between five to 21 days. Now, a new real-time PCR assay accurately detects MPXV specifically with a single test and delivers results within 90 minutes.

Seegene, Inc. (Seoul, Korea) has developed a PCR test to detect the MPXV. The Novaplex MPXV Assay, which specifically targets the MPXV, was swiftly developed using the company's AI-based automated test development system, known as SGDDS (Seegene Digitalized Development System), and technologies refined over 20 years of MDx expertise.

According to the World Health Organization, the MPXV is an "evolving health threat that requires collective attention and coordinated action," calling on member states to step up surveillance, contact tracing and testing. The MPXV has been detected in over 50 nations, with South Korea confirming its first case last week. The strain currently circulating in the Northern Hemisphere has an estimated fatality rate of between 3-6% and is considered especially dangerous for children and those with weak immune systems.

Seegene’s Novaplex MPXV Assay can identify positive cases of the MPXV in 90 minutes. The company swiftly developed the product to help curb the worldwide spread. Seegene plans to provide the assay to countries that have detected the virus.

"The monkeypox virus outbreak shows that endemic viruses can rapidly spread to the rest of the world and it's a warning that new pandemics can emerge and threaten our lives at any time," said Dr. Jong-Yoon Chun, CEO of Seegene. "We will continue our efforts to develop products that can accurately diagnose any virus to help prevent new infectious diseases from taking hold and becoming a pandemic."

Related Links:
Seegene, Inc. 


Gold Member
Automated MALDI-TOF MS System
EXS 3000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Automatic CLIA Analyzer
Shine i9000
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.